Jerusalem (AFP) | 06/08/2026 - 05:39:48 | Israeli military says two soldiers killed in southern Lebanon
Bangkok (AFP) | 06/08/2026 - 05:12:34 | Myanmar leader arrives in Thailand on official visit: entourage
Santiago (AFP) | 06/08/2026 - 04:19:21 | Chile's Kast announces legislative reforms targeting organized crime
Guatemala City (AFP) | 05/08/2026 - 21:48:37 | Guatemalan volcano experts declare end of massive eruption
Leipzig (AFP) | 05/08/2026 - 21:39:10 | Explosive drone at German airport 'a new level of danger': minister
Tehran (AFP) | 05/08/2026 - 21:31:58 | Communication with Mojtaba 'very difficult at moment': Iran president
Abuja (AFP) | 05/08/2026 - 21:19:33 | More than 300 Nigerian kidnapping victims released: govt
Mexico City (AFP) | 05/08/2026 - 20:44:06 | US suspends imports from Mexico's largest avocado producer
Sanaa (AFP) | 05/08/2026 - 20:30:11 | Yemen's Houthis claim attack on another Saudi oil tanker
Detroit (AFP) | 05/08/2026 - 19:28:04 | El-Sayed urges Democrats to 'come together' against Republicans after bruising primary
Olesya Kurpyayeva, Tony Karumba, Josh Edelson, Ernesto Benavides, Luis Tato, and Omar Al-Qattaa have been recognised at the 2026 edition of the Istanbul Photo Awards.
Incyte Biosciences Japan G.K. today announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved Minjuvi® (tafasitamab) in combination with lenalidomide for the treatment of adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL). “This approval provides a new option for patients in Japan living with relapsed or refractory DLBCL, an aggressive disease with historically limited treatment options,” said Yasuyuki Ishida, General Manager, Incyte Biosciences J...
